Description | ||
---|---|---|
Number of patients (eyes) | 28 | (51) |
Age (years), mean (± 1SD) | 39.9 | ±13.0 |
Gender, male (%) | 4 | (14.3) |
Race, n (%) | ||
White | 12 | (42.8) |
Mestizo | 10 | (35.7) |
Black | 4 | (14.3) |
Asian/Oriental | 2 | (7.1) |
Revised Diagnostic Criteria category [14], n (%) | ||
Complete | 7 | (25.0) |
Incomplete | 14 | (50.0) |
Probable | 7 | (25.0) |
Clinical activity (SUN) [15], n (%) | ||
Remission¶ | 11 | (39.3) |
Inactive§ | 5 | (17.8) |
Active | 12 | (42.8) |
Use of systemic medication, n (%) | ||
Prednisone only | 5 | (17.8) |
Prednisone and immunosuppressant | 5 | (17.8) |
Immunosuppressants only | 3 | (10.7) |
None | 15 | (53.6) |
Disease duration (in months), median (range) | 91.5 | (9–348) |